Medline — Third Quarter and Nine Months 2026 Earnings Summary

Medline reported third-quarter 2026 net sales of $7.9 billion, representing a 10.4% increase, while net income declined 1.2% to $318 million due to higher operating expenses and inventory costs. For the nine-month period, net sales reached $22.9 billion, up 10.9%, though net income fell 28.8% to $696 million, significantly impacted by a $316 million loss from a fire at the Tracy, California distribution center. The company raised its full-year 2026 organic sales guidance to a range of 10.0% to 10.5% and reaffirmed adjusted EBITDA guidance of $3.3 billion to $3.4 billion. Additionally, Medline's board authorized a $1 billion share repurchase program and prepaid $750 million of its 2033 Refinancing Term Loan Facility.